Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial

IMPORTANCE: Advantages of using efavirenz as part of treatment for HIV-infected children include once-daily dosing, simplification of co-treatment for tuberculosis, preserving ritonavir-boosted lopinavir for second-line treatment, and harmonization of adult and pediatric treatment regimens. However,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA
Päätekijät: Coovadia, Ashraf, Abrams, Elaine J., Strehlau, Renate, Shiau, Stephanie, Pinillos, Francoise, Martens, Leigh, Patel, Faeezah, Hunt, Gillian, Tsai, Wei-Yann, Kuhn, Louise
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4655876/
https://ncbi.nlm.nih.gov/pubmed/26529159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2015.13631
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia